- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
City of Hope | Strategic Alliance Partners
Latest from City of Hope
Dr Danilov on the Evolution of MCL Treatment
July 11, 2024
Video
Alexey Danilov, MD, PhD, discusses the evolution of treatment for patients with mantle cell lymphoma.
Dr Phillips on Evolving Treatment Strategies in Both MCL and CLL
July 11, 2024
Video
Tycel Phillips, MD, discusses the evolution of treatment strategies for patients with either chronic lymphocytic leukemia or mantle cell lymphoma.
Phillips Discusses Past Progress and Previews the Future in Hematologic Cancers
July 10, 2024
Article
Tycel Phillips, MD, highlights key takeaways in NHL, MDS, and myelofibrosis from an OncLive State of the Science Summit on hematology.
Dr Phillips on the Evolution of BTK Inhibitors in MCL
July 03, 2024
Video
Tycel Phillips, MD, discusses the evolution of treatment with BTK inhibitors for patients with mantle cell lymphoma.
Early Data With DFF332, Other Key Biomarker Analyses Continue to Inform Approaches in RCC
July 03, 2024
Article
Sumanta Kumar Pal, MD, FASCO, highlights key renal cell carcinoma research presented at the 2024 ASCO Annual Meeting, including early data with DFF332.
Dr Phillips on the Evolution of the MCL Treatment Paradigm
June 28, 2024
Video
Tycel Phillips, MD, discusses the evolution of treatment for patients with mantle cell lymphoma.
Ongoing Research Efforts and More in Ph+ Acute Lymphoblastic Leukemia
June 21, 2024
Video
Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss ongoing research efforts in the treatment paradigm of Philadelphia chromosome–positive acute lymphoblastic leukemia.
Safety Data With Ponatinib in PHALLCON for Ph+ Acute Lymphoblastic Leukemia
June 21, 2024
Video
Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss safety findings from the PHALLCON trial of ponatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia.
Clinical Efficacy With Ponatinib in the PHALLCON Trial for Ph+ ALL
June 21, 2024
Video
Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss the efficacy with ponatinib observed in the PHALLCON trial of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia.
The Impact of the Ponatinib FDA Approval in Newly Diagnosed Ph+ ALL
June 21, 2024
Video
Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss the impact of the FDA approval of ponatinib for the treatment of newly diagnosed patients with Philadelphia chromosome–positive acute lymphoblastic leukemia.
Current Standards of Care for Ph+ Acute Lymphoblastic Leukemia
June 21, 2024
Video
Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss current standards of care for the treatment of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia.
Prevalence and Prognosis of Ph+ Acute Lymphoblastic Leukemia
June 21, 2024
Video
Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss the prevalence and prognostic outcomes of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia.
Fixed-Duration Glofitamab Yields Responses in R/R Mantle Cell Lymphoma
June 18, 2024
Article
Tycel Phillips, MD, discusses updated findings from a phase 1/2 trial evaluating glofitamab in relapsed/refractory mantle cell lymphoma.
Dr Aldoss on Responses With WU-CART-007 After Enhanced Lymphodepletion in R/R T-ALL/LBL
June 14, 2024
Video
Ibrahim Aldoss, MD, discusses the impact of enhanced lymphodepletion on responses with WU-CART-007 in relapsed/refractory T-ALL/LBL.
Dr Phillips on the Safety and Efficacy of Glofitamab in Relapsed/Refractory MCL
June 06, 2024
Video
Tycel Phillips, MD, MPH, discusses updated efficacy and safety data with glofitamab for the treatment of relapsed/refractory mantle cell lymphoma.
Revisit Every OncLive On Air Episode From May 2024
May 30, 2024
Article
In case you missed any, below is a recap of every OncLive On Air episode that aired in May 2024.
Key Takeaways in HER2-Mutated NSCLC
May 29, 2024
Video
The panel concludes the discussion with key takeaways on the evolving treatment landscape in HER2 non–small cell lung cancer.
Treatment Considerations in HER2-Mutated NSCLC
May 29, 2024
Video
Experts on HER2 NSCLC provide clinical insights on selecting between antibody-drug conjugates and TKIs, treatment sequencing, and the role of chemoimmunotherapy.
Dr Pal Previews ASCO 2024 Data in Renal Cell Carcinoma
May 23, 2024
Video
Sumanta Kumar Pal, MD, FASCO, discusses key biomarker analyses in renal cell carcinoma that will be presented at the 2024 ASCO Annual Meeting.
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
May 23, 2024
Podcast
Experts from across oncology specialties discuss the abstracts and presentations they are most looking forward to seeing at the 2024 ASCO Annual Meeting.